ASCL1
Achaete-scute homolog 1
Also known as: ASCL1_HUMAN, ASH1, bHLHa46, HASH1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P50553
- Gene
- ASCL1
- Ensembl
- ENSG00000139352
- Chromosome
- 12
- Canonical length
- 236 aa
- Protein class
- Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a member of the basic helix-loop-helix (BHLH) family of transcription factors. The protein activates transcription by binding to the E box (5'-CANNTG-3'). Dimerization with other BHLH proteins is required for efficient DNA binding. This protein plays a role in the neuronal commitment and differentiation and in the generation of olfactory and autonomic neurons. Mutations in this gene may contribute to the congenital central hypoventilation syndrome (CCHS) phenotype in rare cases. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
236 residues, UniProt reviewed canonical sequence.
>P50553|ASCL1
1 MESSAKMESG GAGQQPQPQP QQPFLPPAAC FFATAAAAAA AAAAAAAQSA QQQQQQQQQQ
61 QQAPQLRPAA DGQPSGGGHK SAPKQVKRQR SSSPELMRCK RRLNFSGFGY SLPQQQPAAV
121 ARRNERERNR VKLVNLGFAT LREHVPNGAA NKKMSKVETL RSAVEYIRAL QQLLDEHDAV
181 SAAFQAGVLS PTISPNYSND LNSMAGSPVS SYSSDEGSYD PLSPEEQELL DFTNWFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ASCL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 28 nTPM
- amygdala: 16 nTPM
- hippocampal formation: 12 nTPM
- cerebral cortex: 12 nTPM
- midbrain: 11 nTPM
- liver: 10 nTPM
Single-cell type
- corticotrophs: 260 nCPM
- oligodendrocyte progenitor cells: 86 nCPM
- medullary thymic epithelial cells: 65 nCPM
- neuroendocrine cells: 48 nCPM
- pancreatic islet cells: 25 nCPM
- bergmann glia: 23 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- medulla oblongata: 16 nTPM
- spinal cord: 15 nTPM
- cerebral cortex: 14 nTPM
- white matter: 14 nTPM
- cerebellum: 13 nTPM
- amygdala: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.6
- gnomAD pLI
- 0.68
- gnomAD missense Z
- 1.58
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adrenal chromaffin cell differentiation
- cell maturation
- central nervous system neuron development
- cerebral cortex development
- cerebral cortex GABAergic interneuron differentiation
- commitment of neuronal cell to specific neuron type in forebrain
- heart development
- lung epithelial cell differentiation
- motor neuron migration
- musculoskeletal movement, spinal reflex action
- negative regulation of apoptotic process
- negative regulation of DNA-templated transcription
- negative regulation of neuron differentiation
- negative regulation of transcription by RNA polymerase II
- neuroblast proliferation
- neurogenesis
- neuron development
- neuron differentiation
- neuron fate commitment
- neuron fate specification
- noradrenergic neuron development
- Notch signaling pathway
- olfactory pit development
- oligodendrocyte development
- peripheral nervous system neuron development
- positive regulation of cell cycle
- positive regulation of neural precursor cell proliferation
- positive regulation of neurogenesis
- positive regulation of neuron apoptotic process
- positive regulation of neuron differentiation
- positive regulation of Notch signaling pathway
- positive regulation of transcription by RNA polymerase II
- regulation of epithelial cell differentiation
- regulation of gene expression
- regulation of mitotic cell cycle
- regulation of neurogenesis
- response to epidermal growth factor
- response to folic acid
- response to retinoic acid
- sensory organ development
- spinal cord association neuron differentiation
- spinal cord oligodendrocyte cell fate specification
- stomach neuroendocrine cell differentiation
- subpallium neuron fate commitment
- sympathetic ganglion development
- sympathetic nervous system development
- ventral spinal cord interneuron fate commitment
- vestibular nucleus development
- carotid body glomus cell differentiation
- cellular response to magnetism
- lung neuroendocrine cell differentiation
- neuroblast fate determination
- noradrenergic neuron fate commitment
- regulation of timing of subpallium neuron differentiation
Molecular functions
- bHLH transcription factor binding
- chromatin binding
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- E-box binding
- identical protein binding
- nucleic acid binding
- protein dimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ASCL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ASCL1 as an antibody target. Whether an autoantibody or antibody against ASCL1 could matter depends on whether native ASCL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ASCL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ASCL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...